{"result": "(\"entity\"<|>ENDOCRINE SOCIETY<|>ORGANIZATION<|>The Endocrine Society is a professional organization that provides clinical practice guidelines for the diagnosis and management of endocrine disorders, including Cushing's syndrome and primary aldosteronism.)\n##\n(\"entity\"<|>CUSHING'S SYNDROME<|>EVENT<|>Cushing's syndrome is a hormonal disorder caused by prolonged exposure to high levels of cortisol, leading to various health issues.)\n##\n(\"entity\"<|>HYPERALDOSTERONISM<|>EVENT<|>Hyperaldosteronism is a condition characterized by excessive secretion of the hormone aldosterone, which can lead to hypertension and other health complications.)\n##\n(\"entity\"<|>KCNJ5<|>GENE<|>KCNJ5 is a gene that encodes a potassium channel and is associated with familial hyperaldosteronism type 3, which can cause severe hypertension.)\n##\n(\"entity\"<|>HARRISON PRINCIPLES OF INTERNAL MEDICINE<|>ORGANIZATION<|>Harrison Principles of Internal Medicine is a comprehensive medical textbook that covers various aspects of internal medicine, including endocrine disorders.)\n##\n(\"entity\"<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>ORGANIZATION<|>Williams Textbook of Endocrinology is a key reference book in the field of endocrinology, providing detailed information on hormonal disorders and their management.)\n##\n(\"relationship\"<|>ENDOCRINE SOCIETY<|>CUSHING'S SYNDROME<|>The Endocrine Society provides clinical practice guidelines for the diagnosis and management of Cushing's syndrome<|>8)\n##\n(\"relationship\"<|>ENDOCRINE SOCIETY<|>HYPERALDOSTERONISM<|>The Endocrine Society offers guidelines for the management of primary aldosteronism, which is related to hyperaldosteronism<|>8)\n##\n(\"relationship\"<|>CUSHING'S SYNDROME<|>HYPERALDOSTERONISM<|>Both Cushing's syndrome and hyperaldosteronism are endocrine disorders that involve hormonal imbalances<|>6)\n##\n(\"relationship\"<|>KCNJ5<|>HYPERALDOSTERONISM<|>Mutations in the KCNJ5 gene are associated with familial hyperaldosteronism, which is a form of hyperaldosteronism<|>7)\n##\n(\"relationship\"<|>HARRISON PRINCIPLES OF INTERNAL MEDICINE<|>CUSHING'S SYNDROME<|>Harrison Principles of Internal Medicine includes information on the diagnosis and treatment of Cushing's syndrome<|>5)\n##\n(\"relationship\"<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>CUSHING'S SYNDROME<|>Williams Textbook of Endocrinology provides comprehensive coverage of Cushing's syndrome and its management<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: .\n         varias las causas descritas:                                                                                                                    • Nieman LK, Biller BMK, Findiling JW, Newel-Price J, Savage MO, Steward PM, et al. The diagnosis of Cushing’s syndrome:\n                                                                                                                                                           an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93:1526-40.\n         Alcohol: en su descripción original, las concentraciones urinaria y plasmática de cortisol se                                                   • Steward PM, Newell-Price JDC. The adrenal cortex. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM. Williams Textbook\n                                                                                                                                                           of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 490-555.\n         hallaban elevadas y no se suprimían con dexametasona. Con la abstinencia de alcohol, las\n         alteraciones bioquímicas revierten rápidamente a la normalidad.\n         Depresión: aunque la causa es desconocida, se sabe que los pacientes con depresión pue-                                              5.3 Hiperaldosteronismo\n         den presentar las alteraciones hormonales de los pacientes con síndrome de Cushing. Es-\n         tas alteraciones son reversibles con la corrección de la afección psiquiátrica.\n         Otras     situaciones asociadas              con hipercortisolismo             fisiológico que         pueden asociar al-               15      El hiperaldosteronismo familiar remediable con corticoides es el de:\n         gunas características de síndrome de Cushing son: embarazo, pacientes con obesidad                                                              A.  Tipo 1.\n         grave, especialmente aquellos que presentan obesidad visceral o síndrome de ovario poli-                                                        B.  Tipo 2.\n         quístico y pacientes con diabetes mal controlada.                                                                                               C. Tipo 3.\n         Situaciones asociadas con hipercortisolismo fisiológico que raramente asocian caracte-                                                          D.  Tipo 4.\n         rísticas clínicas de síndrome de Cushing son el estrés físico (enfermedad, hospitalización,\n         dolor), la malnutrición y la anorexia nerviosa, el ejercicio físico crónico intenso, la amenorrea\n         hipotalámica,        los niveles     elevados de globulina transportadora de cortisol (incrementa los\n         niveles de cortisol, pero no de cortisol libre urinario) y la resistencia a los glucocorticoides.\n\n\n\n268                                                                                                                                                                                                                                                                                            269\n---\n                                                                                                                                                                                              SUPRARRENALES                                     5\n\n\n\n     COMENTARIO                                                                                                         o bilateral. Aunque no se conoce exactamente la base molecular de esta enfermedad, los\n     El hiperaldosteronismo primario se produce por un exceso de secreción autónoma de al-                              estudios de asociación familiar la han relacionado con la región 7p22.\n     dosterona por la glándula suprarrenal. Según las últimas series, su prevalencia es superior                        El hiperaldosteronismo familiar de tipo 3 se ha descrito en unas pocas familias y, salvo\n     al 5-10% entre los pacientes con hipertensión arterial.                                                            excepciones, se asocia a un fenotipo agresivo con hipertensión grave y resistente al tra-\n     El hiperaldosteronismo primario puede deberse a:                                                                   tamiento desde la infancia. Esta enfermedad se debe a mutaciones en el gen KCNJ5 que\n                                                                                                                        codifica el canal de potasio Kir 3.4.\n     •  Adenoma suprarrenal productor de aldosterona (enfermedad de Conn).\n     •  Hiperaldosteronismo idiopático por hiperplasia unilateral o bilateral.                                          Referencias:\n                                                                                                                        • Arlt W. Trastornos de la corteza suprarrenal. En: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscazo J, eds. Harrison\n     •  Hiperaldosteronismo familiar.                                                                                     Principios de Medicina Interna. 19.ª edición en español. México DF: Mc Graw Hill; 2016. p. 2309-29.\n     •  Carcinoma suprarrenal productor de aldosterona.                                                                 • Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection,\n                                                                                                                          diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:1889-1916.\n     El hiperaldosteronismo familiar de tipo 1 o hiperaldosteronismo familiar remediable con                            • Lahera Vargas M. Hiperaldosteronismo primario. Manual de Endocrinología y Nutrición. Disponible en: https://manual.seen.es\n                                                                                                                          (última modificación: 25 de noviembre de 2015).\n     glucocorticoides es un síndrome hereditario autosómico dominante, responsable del 1%                               • Young WF, Jr. Diagnosis of primary aldosteronism. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com. Literature\n                                                                                                                          review current through: Apr\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}